Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 10 (1), 33-9

Combined Heart-Lung-Liver, Double Lung-Liver, and Isolated Liver Transplantation for Cystic Fibrosis in Children


Combined Heart-Lung-Liver, Double Lung-Liver, and Isolated Liver Transplantation for Cystic Fibrosis in Children

J P Couetil et al. Transpl Int.


Between June 1990 and September 1995, 8 of 24 children with cystic fibrosis (CF) who were accepted either for combined transplantation or isolated liver transplantation died while waiting for a graft; 11 underwent transplantation and 5 are currently on the waiting list. Of the 11 children who had surgery, 7 (group 1) underwent one of the following procedures: heart-lung-liver (n = 4), sequential double lung-liver (n = 2), or bilateral lobar lung from a split left lung and reduced liver (n = 1). During the same period, the four other children (group 2) underwent isolated liver transplantation (three full-size livers, one partial liver). There was one perioperative death in each group. Pulmonary infection was the most common cause of morbidity in group 1. Other complications in group 1 included tracheobronchial stenosis (n = 2), biliary stricture (n = 2), and severe ascites (n = 2). All were successfully treated. Obliterative bronchiolitis developed in three patients. This was treated with FK 506. In group 2, pulmonary function tests improved or remained stable after liver transplantation. Surgical complications in group 2 included severe ascites (n = 1), biliary stricture (n = 1), and abscess of the liver (n = 1). Actuarial survival was 85.7% +/- 2% in group 1 at 1 year; it remained unchanged at 3 years and was 64.2% at 5 years.

Similar articles

See all similar articles

Cited by 6 PubMed Central articles

  • Management of Portopulmonary Hypertension: New Perspectives
    L Mancuso et al. World J Gastroenterol 19 (45), 8252-7. PMID 24363516. - Review
    Portopulmonary hypertension (PPHTN) is a known complication of cirrhosis. Moderate-to-severe PPHTN implies an extremely poor prognosis. It occurs in 5%-10% of patients re …
  • Liver Involvement in Cystic Fibrosis
    C Brigman et al. Curr Treat Options Gastroenterol 9 (6), 484-96. PMID 17081482.
    The hepatobiliary manifestations of cystic fibrosis (CF) encompass a broad clinical spectrum, from mild steatosis, associated with poor nutrition, to multilobular cirrhos …
  • The Cost-Effectiveness of Neonatal Screening for Cystic Fibrosis: An Analysis of Alternative Scenarios Using a Decision Model
    N Simpson et al. Cost Eff Resour Alloc 3, 8. PMID 16091139.
    Neonatal screening is expensive as a method of diagnosis. Neonatal screening may be a cost-effective intervention if the hypothesised delays in the onset of symptoms are …
  • Partial Splenectomy in Cystic Fibrosis Patients With Hypersplenism
    GH Thalhammer et al. Arch Dis Child 88 (2), 143-6. PMID 12538318. - Case Reports
    We report three cystic fibrosis (CF) patients with hypersplenism who underwent partial splenectomy. The postoperative course was uneventful in two patients; one patient d …
  • Managing Liver Failure
    DA Kelly. Postgrad Med J 78 (925), 660-7. PMID 12496321. - Review
    Liver disease is rare in childhood, but important new developments have altered the natural history and outcome. It is important that clinicians are aware of these diseas …
See all "Cited by" articles

LinkOut - more resources